Sands Capital Life Sciences Pulse Fund II L.P. insider trades
Open-market stock purchases and sales by Sands Capital Life Sciences Pulse Fund II L.P., 10% Owner at Inhibikase Therapeutics, Inc, from SEC Form 4 filings since Nov 21, 2025.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +12%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Nov 21, 2025 | IKT Inhibikase Therapeutics, Inc | Bought | $3M |
Companies traded
- IKT Inhibikase Therapeutics, Inc: 1 buy, last Nov 21, 2025
Get free alerts when Sands Capital Life Sciences Pulse Fund II L.P. files a new trade →